Junctional tachycardia is a fast heart rhythm that originates from the wrong part of the heart, specifically the junction between the upper and lower chambers rather than the heart’s primary pacemaker. Heart rates typically range from 120 to 220 beats per minute. It’s a rare condition that can appear in infants, children after heart surgery, and adults, each with different causes and outlooks.
How the Heart’s Backup Pacemaker Takes Over
Your heart has a built-in electrical system. Normally, every heartbeat starts at the sinoatrial (SA) node, a cluster of cells at the top of the heart that acts as the primary pacemaker. The electrical signal travels down to the atrioventricular (AV) node, which sits at the junction between the upper chambers (atria) and lower chambers (ventricles), before spreading to the rest of the heart.
In junctional tachycardia, the AV node or nearby tissue fires off electrical signals on its own, bypassing the SA node entirely. Think of it like an understudy in a play taking over the lead role, except this understudy runs the show too fast. The AV junction generates rapid, abnormal impulses that drive the heart rate well above its normal pace. Because the signal doesn’t start at the top of the heart the way it should, the normal coordination between the upper and lower chambers gets disrupted.
What It Looks Like on an ECG
Junctional tachycardia is diagnosed with an electrocardiogram (ECG), and it has a recognizable pattern. The hallmark is a missing, inverted, or hidden P wave. The P wave represents the SA node firing and the atria contracting. When the heartbeat originates from the AV junction instead, the P wave either disappears, gets buried inside the QRS complex (the spike representing the ventricles contracting), or appears inverted because the electrical signal travels backward through the atria.
Other characteristics include a regular rhythm, a rate above 100 beats per minute, a relatively narrow QRS complex, and a very short PR interval (less than 0.12 seconds) when a P wave is visible at all. The narrow QRS is important because it tells clinicians the signal is still traveling through the normal conduction pathways below the AV node, which helps distinguish this from more dangerous rhythms originating in the ventricles.
Three Clinical Forms
Congenital Junctional Ectopic Tachycardia
This is the rarest and most serious form. It typically appears in infants younger than six months and runs continuously rather than in episodes. Despite its rarity (less than 1% of pediatric arrhythmias), it carries significant consequences: up to 60% of affected infants develop heart enlargement and heart failure, and the associated mortality rate is around 35%. The persistent fast rate prevents the heart from filling and pumping efficiently, gradually weakening the muscle over time.
Postoperative Junctional Ectopic Tachycardia
This is the most common form in children. It develops after cardiac surgery for congenital heart defects, particularly repairs involving the area near the AV junction, such as those for ventricular septal defects or tetralogy of Fallot. In one study of 594 pediatric cardiac surgeries, about 5.6% of patients developed this arrhythmia. It tends to appear quickly: more than half of cases began within the first 24 hours after surgery, and nearly all started within five days. The good news is that postoperative junctional tachycardia is usually temporary, resolving as surgical inflammation subsides.
Paroxysmal Junctional Tachycardia in Adults
In adults, junctional tachycardia typically occurs in episodes (paroxysmal). It can be triggered by certain medications, electrolyte imbalances, or underlying heart conditions. One well-known trigger is digitalis (digoxin) toxicity. Digoxin is a medication used for heart failure and certain arrhythmias, and when levels climb too high, it can cause the AV junction to fire abnormally. The tricky part is that toxic and therapeutic blood levels of digoxin overlap considerably, so toxicity can develop even at doses that seem appropriate.
Symptoms You Might Notice
The experience depends on how fast the heart is beating and how long it stays that way. During episodes, you may feel a rapid or pounding heartbeat, lightheadedness, shortness of breath, chest discomfort, or fatigue. Some people feel a fluttering sensation in the chest or neck. If episodes are brief, you might barely notice them. If the tachycardia is persistent and uncontrolled, the heart muscle can weaken over weeks to months, a process called tachycardia-induced cardiomyopathy. This is essentially heart failure caused by the heart running too fast for too long, and it’s the main long-term risk of untreated junctional tachycardia.
How It Differs From Similar Arrhythmias
Junctional tachycardia can look very similar to another common arrhythmia called AV nodal reentrant tachycardia (AVNRT) on an ECG. Both produce a fast, regular, narrow-complex rhythm. The distinction matters because the treatment approach differs significantly, particularly when catheter ablation is being considered.
AVNRT involves an electrical circuit that loops within the AV node, while junctional tachycardia involves a single focus firing rapidly without a reentrant loop. During an electrophysiology study, cardiologists use carefully timed electrical signals to tell them apart. In AVNRT, disrupting one limb of the circuit (the fast pathway) will stop the arrhythmia. In junctional tachycardia, the same maneuver won’t terminate it because there’s no circuit to break. Because of this overlap, paroxysmal junctional tachycardia in adults is largely a diagnosis of exclusion: AVNRT and other similar rhythms need to be ruled out first through careful electrophysiology testing.
Treatment Options
For acute episodes, medications that slow conduction through the AV node are the first-line approach. Beta blockers and calcium channel blockers (like diltiazem or verapamil) are the most commonly used. These work by calming the electrical activity in the AV junction and slowing the heart rate. For ongoing management, oral versions of the same medications are typically continued to prevent recurrent episodes.
If you don’t have underlying structural heart disease, additional rhythm-control medications may be an option. The goal of long-term medication is to reduce the frequency and severity of episodes enough that the heart isn’t under constant strain.
Catheter ablation, a procedure where a thin wire is threaded to the heart to destroy the tissue causing the abnormal rhythm, is reserved for cases where medications don’t work or can’t be tolerated. The procedure has a notable catch: because the abnormal tissue sits very close to the AV node, there’s a meaningful risk of damaging the normal conduction system. In one multicenter study of 12 adults who underwent ablation, the initial success rate was 100%, and none developed heart block during the first procedure. However, 66% experienced a recurrence. Among those who needed a second ablation, half developed severe heart block requiring a permanent pacemaker. This risk profile means ablation is approached cautiously, and the decision involves weighing the burden of the arrhythmia against the chance of needing a pacemaker.
Outlook by Type
Prognosis varies sharply depending on the form. Postoperative junctional tachycardia in children generally resolves on its own within days as the heart heals from surgery, and the long-term outlook is good. Adult paroxysmal junctional tachycardia is typically manageable with medication, and most people live normally between episodes. If a reversible trigger like digoxin toxicity is identified and corrected, the arrhythmia may not return at all.
The congenital form in infants carries the most serious prognosis because of its persistent nature and the difficulty of controlling it in very young patients. Early recognition and aggressive heart rate control are critical to preventing irreversible heart muscle damage. Regardless of the type, the central concern with any form of junctional tachycardia is preventing the heart from running fast long enough to weaken, which is why sustained or frequently recurring episodes warrant close monitoring and treatment.